Network Meta-analysis (NMA) of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Compared with other Triple Therapies for the Treatment of chronic obstructive Pulmonary Disease (COPD): A Comparison of annualized Rates of moderate and severe Exacerbations

被引：0

作者：

Ismaila, A. ^{[1
]}

Haeussler, K. ^{[2
]}

Czira, A. ^{[3
]}

Youn, J. ^{[4
]}

Malmenaes, M. ^{[5
]}

Risebrough, N. ^{[6
]}

Nassim, M. ^{[2
]}

Sharma, R. ^{[3
]}

Compton, C. ^{[3
]}

Vogelmeier, C. ^{[7
]}

Halpin, D. ^{[8
]}

机构：

[1] Gsk, R&D Global Med, 1250 S Collegeville Rd, Collegeville, PA 19426 USA

[2] Icon Plc, Konrad Zuse Pl 11, D-81829 Munich, Germany

[3] Gsk, R&D Global Med, 980 Great West Rd, Brentford, England

[4] Icon Plc, Summit House,12 Red Lion Sq, London WC1R 4HQ, England

[5] Icon Plc, Klarabergsviadukten 90 Hus B, S-11164 Stockholm, Sweden

[6] Icon Plc, Unit400,3455 North Serv Rd, Burlington, ON L7N 3G2, Canada

[7] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Deutsch Zentrum Lungenforsch Dzl, Klin Innere Med,Schwerpunkt Pneumol, Marburg, Germany

[8] Univ Exeter, Univ Exeter Med Sch, Coll Med & Hlth, Exeter, Devon, England

来源：

PNEUMOLOGIE | 2023年 / 77卷

关键词：

D O I：

10.1055/s-0043-1761102

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Po 408

引用

页码：S96 / S96

页数：1

共 23 条